Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema (Q34315346)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema |
scientific article |
Statements
1 reference
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema (English)
1 reference
Peter A Campochiaro
1 reference
David M Brown
1 reference
Andrew Pearson
1 reference
Sanford Chen
1 reference
David Boyer
1 reference
Jose Ruiz-Moreno
1 reference
Bruce Garretson
1 reference
Seenu M Hariprasad
1 reference
Clare Bailey
1 reference
Elias Reichel
1 reference
Gisele Soubrane
1 reference
Barry Kapik
1 reference
Kathleen Billman
1 reference
Frances E Kane
1 reference
Kenneth Green
1 reference
FAME Study Group
1 reference
1 reference
Identifiers
1 reference